Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 3
2014 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds.
Immonen JA, Zagon IS, McLaughlin PJ. Immonen JA, et al. Adv Wound Care (New Rochelle). 2014 Jun 1;3(6):419-427. doi: 10.1089/wound.2014.0543. Adv Wound Care (New Rochelle). 2014. PMID: 24940556 Free PMC article.
Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.
Immonen JA, Zagon IS, McLaughlin PJ. Immonen JA, et al. Exp Biol Med (Maywood). 2014 Oct;239(10):1300-9. doi: 10.1177/1535370214543061. Epub 2014 Jul 16. Exp Biol Med (Maywood). 2014. PMID: 25030485
Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis.
McLaughlin PJ, Immonen JA, Zagon IS. McLaughlin PJ, et al. Among authors: immonen ja. Exp Biol Med (Maywood). 2013 Jul;238(7):733-43. doi: 10.1177/1535370213492688. Epub 2013 Jun 20. Exp Biol Med (Maywood). 2013. PMID: 23788174
Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
Zagon IS, Sassani JW, Immonen JA, McLaughlin PJ. Zagon IS, et al. Among authors: immonen ja. Clin Exp Ophthalmol. 2014 Mar;42(2):159-68. doi: 10.1111/ceo.12144. Epub 2013 Jul 29. Clin Exp Ophthalmol. 2014. PMID: 23777539
Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats.
McLaughlin PJ, Pothering CA, Immonen JA, Zagon IS. McLaughlin PJ, et al. Among authors: immonen ja. Exp Biol Med (Maywood). 2011 Oct;236(10):1122-32. doi: 10.1258/ebm.2011.011163. Epub 2011 Sep 14. Exp Biol Med (Maywood). 2011. PMID: 21917593
Topical treatment with the opioid antagonist naltrexone accelerates the remodeling phase of full-thickness wound healing in type 1 diabetic rats.
Immonen JA, Zagon IS, Lewis GS, McLaughlin PJ. Immonen JA, et al. Exp Biol Med (Maywood). 2013 Oct;238(10):1127-35. doi: 10.1177/1535370213502632. Epub 2013 Aug 28. Exp Biol Med (Maywood). 2013. PMID: 23986225
Feedback